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Abstract
Background—Rotavirus illness has been linked to childhood seizures. We investigated whether 
a protective association exists between receipt of rotavirus vaccine and being hospitalized or 
visiting the emergency department for seizures in the year after vaccination.
Methods—We retrospectively analyzed a cohort of children born after 28 February 2006 (when 
rotavirus vaccine was licensed in the United States) and enrolled in the Vaccine Safety Datalink 
(VSD) through November 2009. Seizure rates from 4 to 55 weeks following last rotavirus 
vaccination were compared by vaccine exposure status (fully vaccinated and unvaccinated). A 
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time-to-event analysis using a Cox proportional hazards model was performed, accounting for 
time-varying covariates. We calculated the relative incidence of seizure compared by vaccine 
exposure status during the postexposure interval.
Results—Our cohort contained VSD data on 250 601 infants, including 186 502 children fully 
vaccinated (74.4%) and 64 099 (25.6%) not vaccinated with rotavirus vaccine. Rates of seizures 
were associated with rotavirus vaccination status. After adjusting for covariates (VSD site, age at 
last dose, sex, and calendar month of the index date), a statistically significant protective 
association was observed between a full course of rotavirus vaccination vs no vaccination for both 
first-ever seizures (risk ratio [RR] = 0.82; 95% confidence interval [CI], .73–.91) and all seizures 
(RR = 0.79; 95% CI, .71–.88).
Conclusions—A full course of rotavirus vaccination was statistically associated with an 18%–
21% reduction in risk of seizure requiring hospitalization or emergency department care in the 
year following vaccination, compared with unvaccinated children. This reduction in childhood 
seizures complements the well-documented vaccine-related benefit of preventing US diarrhea 
hospitalizations.
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Since the introduction of rotavirus vaccines for universal vaccination of infants in the United 
States (RotaTeq [RV5], Merck Vaccines, Whitehouse Station, New Jersey; Rotarix [RV1], 
GlaxoSmithKline Biologicals, Rixensart, Belgium), vaccination against rotavirus has 
resulted in substantial declines in severe gastroenteritis among US children [1–5].
Rotavirus infection is not limited to the intestine and is associated with antigenemia in 
approximately one-half of children hospitalized with rotavirus gastroenteritis [6–9]. 
Furthermore, rotavirus has been isolated in cell culture from the sera of infected children, 
thus confirming that the existence of viremia and the potential for systemic illness exists [6]. 
Wild-type rotavirus has been detected in cerebrospinal fluid by polymerase chain reaction 
and electron microscopy in cases of seizure occurring with diarrhea [10–13]. Clinical 
neurologic illness has been linked to rotavirus infection in numerous studies and case reports 
[14–19]. One of the largest, a multicenter study of 1359 patients hospitalized with 
laboratory-confirmed rotavirus in Canada from 2005 to 2007, reported that 7% of these 
subjects experienced a seizure [20]. A retrospective cohort analysis at a single US hospital 
from 2002 to 2006 reported that 6 of 34 children (18%) hospitalized with rotavirus-
associated seizures spent at least 1 day in an intensive care unit, and a lumbar puncture was 
performed on 20 of these 34 children (59%) [21].
Gastroenteritis-associated seizures often occur in clusters (>1 seizure in 24 hours) and while 
the child is afebrile [22]. These events may be more likely than febrile seizures to prompt 
emergent care, invasive diagnostic procedures, and follow-up medical care and/or 
medication, and are not included in guidelines addressing the management of children with 
simple febrile seizures [23–25].
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With the clinically observed relationship between natural rotavirus infections and seizures, 
we studied a retrospective cohort of children enrolled in the Vaccine Safety Datalink (VSD) 
to investigate whether a protective association exists between receipt of rotavirus 
vaccination and being hospitalized or receiving care at an emergency department (ED) for 
seizure the year following vaccination.
METHODS
We retrospectively analyzed a cohort of children born from March 2006 through November 
2009 enrolled in the VSD to estimate the relative risk of seizures recorded in inpatient and 
ED settings by rotavirus vaccination status.
Vaccine Safety Datalink
VSD is a collaborative project between the Centers for Disease Control and Prevention 
(CDC) and managed care organizations (MCOs) throughout the United States. Participating 
MCOs capture epidemiological, clinical, and vaccination data on approximately 3% of the 
US population (8.8 million persons) annually for the purpose of vaccine safety research [26, 
27]. Eight VSD MCOs contributed data to this study, including Group Health Cooperative 
of Puget Sound (Seattle, Washington), Kaiser Permanente Northwest (Portland, Oregon), 
Kaiser Permanente Medical Care Program of Northern California (Oakland, California), 
Southern California Kaiser Permanente Health Care Program (Los Angeles, California), 
Harvard Pilgrim Health Care (Boston, Massachusetts), Health Partners Research Foundation 
(Minneapolis, Minnesota), Marshfield Clinic Research Foundation (Marshfield, Wisconsin), 
and Kaiser Permanente Colorado (Denver, Colorado). This study was approved by 
institutional review boards at the CDC and at each participating VSD institution.
Definition of Rotavirus Vaccination Exposure
We used VSD records to identify the dates of rotavirus vaccination for subjects born after 28 
February 2006, when RV5 was licensed. Subjects having 3 recorded RV5 vaccinations and 2 
recorded RV1 vaccinations were considered fully vaccinated, and subjects receiving no 
doses were considered unvaccinated. For this time period, our database included mostly 
RV5 vaccinations (>99%), although we did include children receiving RV1 and classified 
them according to Advisory Committee on Immunization Practices (ACIP) 
recommendations.
Definition of Seizures
Seizure cases were identified by the International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) codes 780.3* (convulsions), 779.0* (convulsions in 
newborn), 333.2* (myoclonus), or 345* (epilepsy) occurring in the VSD hospitalization or 
ED automated files. Results from a separate study suggested that the positive predictive 
value (PPV) of VSD inpatient and ED ICD-9-CM data for seizures is relatively high. In that 
VSD data quality assessment, 859 VSD-recorded seizures (identified using the same ICD-9-
CM codes as our study) among children 6 weeks to 23 months of age were compared with 
medical chart review findings. These codes were demonstrated to have a PPV of 97% and 
64% for the hospital and ED clinical settings, respectively [28].
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Diagnoses of seizures were obtained from hospital and ED visit discharge codes occurring 
29–388 days (approximately 4–55 weeks) following last rotavirus vaccination, which 
allowed sufficient time for rotavirus vaccine–mediated immunity to be established. 
Censoring occurred for subjects having no diagnoses of these conditions at the end of the 
postexposure interval. Analyses focused on the aggregate risk for this postexposure interval, 
with 6 successive 59-day subsets analyzed to indicate whether trends in risk were apparent 
over time.
Sample Selection
Children born after 28 February 2006 were selected and characterized by vaccination status 
(fully vaccinated and unvaccinated). The date of last rotavirus vaccination served as the 
index date for those vaccinated. For unvaccinated children, an index date was randomly 
selected by a computer program to fall within the age recommended by ACIP [29] for 
receiving rotavirus vaccination. Study subjects with VSD records for at least 1 year were 
retained in the sample.
Statistical Analyses
A time-to-event analysis using a Cox proportional hazards model was performed, 
accounting for time-varying covariates. The retrospective cohort method calculated the 
relative incidence of seizure compared by vaccine exposure status during the postexposure 
interval.
We compared the characteristics of children whose complete vaccination records indicated 
that they received some vaccines but not rotavirus vaccine, with those children having 
received recommended vaccines including rotavirus vaccine. Additional analyses compared 
children who received partial courses of rotavirus vaccine and, although our results for 
partially vaccinated children were comparable to those from fully vaccinated children, these 
were not statistically significant and are not shown. Subjects having no ACIP-recommended 
childhood vaccinations were excluded from analysis, as they likely differed from those who 
received these vaccinations.
We estimated the postexposure interval hazard (risk) of seizure using a model comparing 
fully vaccinated children to those receiving no rotavirus vaccination. We calculated risks for 
the full risk period following last rotavirus dose, as well as risks for 6 equal time periods 
(29–88 days, 89–148 days, 149–208 days, 209–268 days, 269–328 days, and 329–388 days). 
For each model, we controlled for the VSD site, age at last dose, sex, index month, and year.
RESULTS
In our original VSD cohort of 260 666 children, 186 513 were fully immunized with 
rotavirus vaccines and 74 153 were not immunized with any rotavirus vaccine. More than 
99% of those fully immunized received at least 1 other recommended vaccine, whereas 86% 
of those not immunized with rotavirus vaccine received at least 1 other recommended 
vaccine (96.8% of total). We limited our analysis to those children having at least 1 other 
Payne et al. Page 4













recommended vaccine to avoid potential bias coassociated with vaccination status and 
healthcare utilization. Therefore, our final analysis cohort contained VSD data on 250 601 
children, including 186 502 children fully immunized with rotavirus vaccines (74.4%) and 
64 099 (25.6%) not immunized with rotavirus vaccine.
Fully immunized children ranged from 38% to 64% of the cohort total by VSD site. All but 
1 site had >50% of children fully immunized. The proportion not immunized against 
rotavirus at all ranged from 15% to 45%. Those who were fully vaccinated were older than 
unvaccinated children (P < .001; Table 1).
We identified 2244 first-time cases of seizures following the index date (1575 fully 
vaccinated and 669 unvaccinated). Of subjects with seizures, 1713 (68%) were evaluated in 
the ED and 74% of these ED patients received at least 1 rotavirus vaccination, compared 
with 72% of those hospitalized receiving an immunization (P = .209). Among unvaccinated 
children, 55% of all seizures occurred during the traditional rotavirus season (January–June), 
whereas 48%–49% of seizures occurred during these months among vaccinated children (P 
= .023). Seizure rates were statistically related to vaccination status. Among fully vaccinated 
and unvaccinated children, first-time seizures occurred at a rate of 1145 and 1212 per 100 
000 person-years, respectively, and all seizures occurred at a rate of 1383 and 1502 per 100 
000 person-years, respectively (Table 2).
After adjusting for covariates, a statistically significant protective association was observed 
between a full course of rotavirus vaccination and first-ever seizures (risk ratio [RR] = 
0.816; 95% confidence interval [CI], .729–.914]), and for all seizures (RR = 0.790; 95% 
CI, .714–.875) Table 2).
DISCUSSION
We observed that rotavirus vaccination was statistically associated with an approximate 
18%–21% reduction in risk of seizures requiring hospitalization or ED care in the year 
following vaccination, compared with unvaccinated children. This additional, and somewhat 
unanticipated, potential benefit of rotavirus vaccination complements the well-documented 
vaccine-related benefit of preventing US diarrhea hospitalizations.
Overall, seizures are estimated to contribute to 1%–2% of the annual burden in pediatric 
hospitalizations and ED visits in the United States [30–32]. Based on these published 
estimates, our observed reduction in risk could potentially translate to the prevention of 
approximately 1000 hospitalizations and 5000 ED visits for seizures per year among young 
children. Seizure-related hospitalizations and ED visits each cost approximately $4553 
(2006) [30] and $498 (2007), respectively [31]; therefore, this finding could amount to >$7 
million in prevented healthcare costs per year, should our reported association be fully and 
causally related. Additionally, the averted emotional toll to family members, the avoidance 
of potentially painful procedures to the young child, and obviated antiseizure medication 
regimens would accrue further benefits.
A previous analysis of the VSD dataset using a sequential analysis method from May 2006 
through May 2008 explored the relationship between seizures and RV5 vaccination during 
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only the first 30 days after receipt of vaccine and found a relative risk of 0.67, although the 
null hypothesis was not rejected in that analysis [33]. Our longer-term and statistically 
significant results support this short-term indication, as do the many published clinical 
reports that strongly indicate a biological plausibility of this association [14–20]. Several 
mechanisms may explain this protective association between rotavirus vaccination and 
seizures, with the most probable mechanism being that vaccination directly prevents 
systemic rotavirus infection, including extraintestinal complications involving the central 
nervous system [34]. Vaccination may also prevent secondary effects of rotavirus infection, 
including a rotavirus-related elevation of nitric oxide in cerebrospinal fluid inducing 
neurotoxicity [35, 36], and/or calcium channel fluctuations resulting in neurotransmitter 
dysregulation [37–39].
Although the majority of our subjects were between 8 and 18 months of age, the peak 
occurrence of febrile seizures is between 18–24 months and the peak age for nonfebrile 
seizures is <12 months of age [40–42]. Therefore, our results may disproportionately capture 
the effect of vaccination upon nonfebrile seizures. However, these nonfebrile seizures may 
be etiologically most relevant to acute gastroenteritis infections and less genetically 
influenced than febrile seizures. Retrospective studies of first-time seizures occurring with 
mild acute illness found that diarrhea or gastroenteritis was a common feature of illness in 
children with first-time seizures, and was more common in children with nonfebrile seizures 
compared to children with febrile seizures (38%–52% vs 11%–16%, P < .001) [22, 43, 44].
Some limitations should be considered. First, >99% of our studied rotavirus vaccination 
events consisted of RV5 vaccine, so our results are not generalizable to RV1 vaccine. 
Second, our study does not differentiate between clinical subgroups of seizure types. Third, 
we were unable to control for underlying conditions that could be associated both with 
getting vaccinated and with seizure, such as gestational prematurity, or for some other 
seizure-causing pathogen having similar seasonality among the same age groups. Fourth, 
children in the VSD population are enrolled in MCOs and are not necessarily representative 
of all US children, and these possible differences may include factors related to 
immunization. Results for partially vaccinated children were comparable to those from fully 
vaccinated children, but were not statistically significant. Last, we assessed the level of 
potential bias in using ICD-9-CM codes for seizures in the VSD database, applying our risk 
ratio of 0.79 and the high PPV of 0.81 published by Shui et al [28]. We calculated that any 
such bias in our study would be directed towards the null and would be relatively small.
In conclusion, we found that a full course of rotavirus vaccination was associated with 
statistically significant reductions in the risk of childhood seizures during the year following 
last rotavirus vaccination. This reduction in childhood seizures complements the well-
documented vaccine-related benefit of preventing US diarrhea hospitalizations.
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Table 1
Characterization of Subjects in the Analytical Cohort by Rotavirus Vaccination Status
Variable Not Vaccinated (n = 64 099), No. Full Vaccination (n = 186 502), No. P Value
Age
 6–11 wk 0 4 (<1%) <.001a
 12–19 wk 1018 (2%) 1651 (1%)
 20–34 wk 5839 (9%) 3434 (2%)
 35–48 wk 57 242 (89%) 181 413 (97%)
Sex
 Female 30 958 (48%) 91 241 (49%) .006a
 Male 33 141 (52%) 95 261 (51%)
Seizure
 Yes 669 (1%) 1575 (1%) <.001a
 No 63 429 (99%) 184 920 (99%)
Seasonality of seizure event
 January–June 369 (55%) 774 (49%) .010a
 July–December 300 (45%) 801 (51%)
Days since vaccination that seizure occurredb
 29–88 d 99 (15%) 249 (16%) .581
 89–148 d 114 (17%) 246 (16%)
 149–208 d 114 (17%) 297 (19%)
 209–268 d 140 (21%) 345 (22%)
 269–328 d 139 (21%) 285 (18%)
 329–388 d 63 (9%) 153 (10%)
For unvaccinated children, an index date was randomly selected by a computer program to fall within the age recommended by the Advisory 




The date of last rotavirus vaccination serves as the index date for those vaccinated.
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Table 2
Cox Proportional Hazards Model Results for Risk of Seizure Following Rotavirus Vaccination
Vaccination Exposure (First) Seizure Rate (per 100 000 PY) Strata Risk Ratio (95% CI)a
None 1212 1.000
Full course 1145 First-ever seizure 0.816 (.729–.914)b
All seizures 0.790 (.714–.875)b
Abbreviations: CI, confidence interval; PY, person-years.
a
Models were adjusted for sex, age at last vaccine dose, Vaccine Safety Datalink site, index month, and year.
b
Statistically significant finding.
Clin Infect Dis. Author manuscript; available in PMC 2015 October 24.
